RBC Capital Boosts Price Target on Splunk (NASDAQ:SPLK) to $125 From $120
RBC Capital Boosts Price Target on Splunk (NASDAQ:SPLK) to $125 From $120, Cites ‘Strong’ Quarter, Outlook; Outperform Rating Kept.
RBC Capital Boosts Price Target on Splunk (NASDAQ:SPLK) to $125 From $120, Cites ‘Strong’ Quarter, Outlook; Outperform Rating Kept.
RBC Capital analyst Mark Dwelle maintains MetLife (NYSE:MET) with a Outperform and lowers the price target from $76 to $68.
RBC Capital analyst Mike Dahl upgrades Toll Brothers (NYSE:TOL) from Sector Perform to Outperform and raises the price target from $55 to $77.
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $89 price target.
RBC Capital analyst Tom Narayan reiterates Mobileye Global (NASDAQ:MBLY) with a Outperform and maintains $42 price target.
RBC Capital analyst Ben Hendrix reiterates CVS Health (NYSE:CVS) with a Outperform and maintains $102 price target.
RBC Capital analyst Mark Dwelle maintains American Intl Gr (NYSE:AIG) with a Outperform and lowers the price target from $75 to $70.
RBC Capital Trims Price Target on NextEra Energy Partners (NYSE:NEP) to $73 From $74, Maintains Outperform Rating.
RBC Capital analyst Deane Dray reiterates 3M (NYSE:MMM) with a Underperform and maintains $95 price target.
RBC Capital analyst Brad Erickson reiterates Booking Holdings (NASDAQ:BKNG) with a Outperform and maintains $2750 price target.